Royal Bank Of Canada Issues Positive Forecast for Calian Group (TSE:CGY) Stock Price

Calian Group (TSE:CGY) had its price target lifted by Royal Bank Of Canada from C$58.00 to C$60.00 in a research note issued to investors on Friday,BayStreet.CA reports. They currently have an outperform rating on the stock.

CGY has been the topic of a number of other reports. Desjardins boosted their price target on shares of Calian Group from C$59.00 to C$66.00 and gave the stock a “buy” rating in a research note on Thursday, November 27th. Ventum Financial lifted their price objective on shares of Calian Group from C$62.00 to C$72.00 and gave the company a “buy” rating in a report on Tuesday, January 27th. Canaccord Genuity Group upped their target price on shares of Calian Group from C$63.00 to C$80.00 in a research note on Friday. Finally, Canadian Imperial Bank of Commerce increased their target price on shares of Calian Group from C$65.00 to C$76.00 in a report on Friday. Six analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock presently has an average rating of “Buy” and an average target price of C$74.83.

Calian Group Trading Up 6.7%

CGY opened at C$70.60 on Friday. Calian Group has a 52 week low of C$37.70 and a 52 week high of C$71.92. The business has a fifty day simple moving average of C$60.38 and a 200-day simple moving average of C$54.12. The firm has a market cap of C$805.62 million, a P/E ratio of 40.11, a P/E/G ratio of 2.50 and a beta of 0.70. The company has a quick ratio of 1.20, a current ratio of 1.29 and a debt-to-equity ratio of 39.54.

Calian Group (TSE:CGY) last posted its quarterly earnings data on Thursday, February 12th. The company reported C$1.03 earnings per share (EPS) for the quarter. Calian Group had a return on equity of 3.37% and a net margin of 1.50%.The firm had revenue of C$208.00 million for the quarter. On average, equities analysts expect that Calian Group will post 4.9475219 earnings per share for the current year.

Calian Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 11th. Investors of record on Wednesday, March 11th will be issued a $0.28 dividend. The ex-dividend date of this dividend is Wednesday, February 25th. This represents a $1.12 annualized dividend and a yield of 1.6%. Calian Group’s dividend payout ratio (DPR) is 63.64%.

Key Headlines Impacting Calian Group

Here are the key news stories impacting Calian Group this week:

• Positive Sentiment: Record Q1 results — Calian reported C$208M revenue (up ~12% YoY) with margin gains and C$1.03 EPS, and management signaled confident growth on the earnings call; this strengthens the growth narrative driving buying interest. Calian Delivers Record Q1 Revenue and Margin Gains
• Positive Sentiment: Multiple analyst target upgrades — Acumen (to C$85, Buy), Canaccord (to C$80), CIBC (to C$76) and Ventum (to C$82, Buy) raised price targets, signaling broad analyst optimism and providing upward catalyst for the stock. Analyst Ratings Roundup
• Positive Sentiment: Quarterly dividend declared — Board approved a C$0.28 quarterly dividend (annualized yield ~1.6%), with ex-dividend Feb 25 and record Mar 11; supports shareholder return profile and can attract income-minded buyers.
• Neutral Sentiment: Corporate governance update — Shareholders re?elected the board and named Valerie Sorbie as Chair, which preserves leadership continuity but is unlikely to move the stock materially by itself. Shareholder Meeting Results
• Negative Sentiment: RBC’s moderate target bump to C$60 — Although RBC maintained an “outperform” stance, its target remains well below the current price, indicating at least one major analyst sees less upside and creating potential resistance or caution among some investors. RBC Target Update

About Calian Group

Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.